NO20021234L - Anvendelse av tienopyrimidiner - Google Patents

Anvendelse av tienopyrimidiner

Info

Publication number
NO20021234L
NO20021234L NO20021234A NO20021234A NO20021234L NO 20021234 L NO20021234 L NO 20021234L NO 20021234 A NO20021234 A NO 20021234A NO 20021234 A NO20021234 A NO 20021234A NO 20021234 L NO20021234 L NO 20021234L
Authority
NO
Norway
Prior art keywords
thienopyrimidines
Prior art date
Application number
NO20021234A
Other languages
English (en)
Other versions
NO20021234D0 (no
Inventor
Rochus Jonas
Volker Eiermann
Sabine Bernotat-Danielowski
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20021234D0 publication Critical patent/NO20021234D0/no
Publication of NO20021234L publication Critical patent/NO20021234L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20021234A 1999-09-14 2002-03-13 Anvendelse av tienopyrimidiner NO20021234L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19943815A DE19943815A1 (de) 1999-09-14 1999-09-14 Verwendung von Thienopyrimidinen
PCT/EP2000/008258 WO2001019369A1 (de) 1999-09-14 2000-08-24 Verwendung von thienopyrimidinen

Publications (2)

Publication Number Publication Date
NO20021234D0 NO20021234D0 (no) 2002-03-13
NO20021234L true NO20021234L (no) 2002-03-13

Family

ID=7921854

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021234A NO20021234L (no) 1999-09-14 2002-03-13 Anvendelse av tienopyrimidiner

Country Status (18)

Country Link
EP (1) EP1212062A1 (no)
JP (1) JP2003509370A (no)
KR (1) KR20020026011A (no)
CN (1) CN1377271A (no)
AR (1) AR025645A1 (no)
AU (1) AU6703200A (no)
BR (1) BR0013957A (no)
CA (1) CA2387123A1 (no)
CZ (1) CZ2002818A3 (no)
DE (1) DE19943815A1 (no)
HU (1) HUP0202614A3 (no)
MX (1) MXPA02002746A (no)
NO (1) NO20021234L (no)
PL (1) PL353343A1 (no)
RU (1) RU2002107441A (no)
SK (1) SK3322002A3 (no)
WO (1) WO2001019369A1 (no)
ZA (1) ZA200202868B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03005441A (es) * 2000-12-19 2003-09-10 Merck Patent Gmbh Formulacion farmaceutica que contiene tienopirimidinas y antitromboticos, antagonistas de calcio, prostaglandinas o derivados de prostaglandina (2).
DE10135815A1 (de) * 2001-07-23 2003-02-06 Bayer Ag Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
HU228446B1 (en) * 1996-04-12 2013-03-28 Warner Lambert Co Kinazoline derivatives as irreversible inhibitors of protein-kinase, pharmaceutical compositions containing these compounds and use thereof
DE19644228A1 (de) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
DE19819023A1 (de) * 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine
US5948911A (en) * 1998-11-20 1999-09-07 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivatives
EP1167367A4 (en) * 1999-03-30 2002-04-24 Nippon Soda Co THIENOPYRIMIDINE COMPOUNDS AND SALTS THEREOF, AND PROCESS FOR THE PREPARATION THEREOF

Also Published As

Publication number Publication date
AU6703200A (en) 2001-04-17
ZA200202868B (en) 2003-11-26
CZ2002818A3 (cs) 2002-06-12
HUP0202614A2 (hu) 2002-12-28
BR0013957A (pt) 2002-05-21
NO20021234D0 (no) 2002-03-13
WO2001019369A1 (de) 2001-03-22
PL353343A1 (en) 2003-11-17
KR20020026011A (ko) 2002-04-04
RU2002107441A (ru) 2003-11-20
SK3322002A3 (en) 2002-07-02
JP2003509370A (ja) 2003-03-11
CA2387123A1 (en) 2001-03-22
CN1377271A (zh) 2002-10-30
DE19943815A1 (de) 2001-03-15
AR025645A1 (es) 2002-12-04
HUP0202614A3 (en) 2004-11-29
EP1212062A1 (de) 2002-06-12
MXPA02002746A (es) 2002-10-23

Similar Documents

Publication Publication Date Title
AR028567A1 (es) Nuevos derivados de fenil-propargileter
ID30233A (id) Antibiotika ketolida
AR028596A1 (es) Nuevos derivados de fenilglicina
ID30187A (id) Dongkrak jenis pantagraf
PL361277A1 (en) Use of thienopyrimidines
NO20041968L (no) Anvendelse av cystationin
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
PT1022396E (pt) Combinacao de duche
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
PT1175417E (pt) Compostos substituidos de benzolactamas
NO20021234L (no) Anvendelse av tienopyrimidiner
PT1232141E (pt) Eteres de o-desmetil-venlafaxina
PT1020132E (pt) Aba de puxar destacavel
NO20016030D0 (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
NO20005856D0 (no) Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner
SE9902239D0 (sv) Kornisch bestående av flera delar
NO20022671D0 (no) Fremgangsmåte for fremstilling av tienopyrimidiner
EE200200053A (et) Isoretinoiini valmistamise protsess
SE9904269D0 (sv) Use of new responsive elements
SE9903009D0 (sv) Use of new responsive elements
FI4225U1 (fi) Teknisen laitteiston erikoisosa
SE9901114D0 (sv) Reducering av Nox

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application